Characterizing antiprion compounds based on their binding properties to prion proteins: implications as medical chaperones.

Characterizing antiprion compounds based on their binding properties to prion proteins: implications as medical chaperones.

Item
http://www.wikidata.org/entity/Q34307103
The crystal structure of an octapeptide repeat of the Prion protein in complex with a Fab fragment of the POM2 antibodyAnti-prion activity of a panel of aromatic chemical compounds: in vitro and in silico approachesSuccesses and challenges in phenotype-based lead discovery for prion diseasesDiscovery of Novel Anti-prion Compounds Using In Silico and In Vitro ApproachesA cationic tetrapyrrole inhibits toxic activities of the cellular prion protein.Pharmacological chaperone reshapes the energy landscape for folding and aggregation of the prion proteinQuinacrine promotes replication and conformational mutation of chronic wasting disease prions.Insights from Therapeutic Studies for PrP Prion Disease.In silico strategies on prion pathogenic conversion and inhibition from PrPC -PrPSc.A Native-like Intermediate Serves as a Branching Point between the Folding and Aggregation Pathways of the Mouse Prion Protein.Structural insight into the antiprion compound inhibition mechanism of native prion folding over misfolding.Pharmacological Agents Targeting the Cellular Prion Protein.
P2860

Characterizing antiprion compounds based on their binding properties to prion proteins: implications as medical chaperones.

Item
http://www.wikidata.org/entity/Q34307103
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Characterizing antiprion compo ...... cations as medical chaperones.
@ast
Characterizing antiprion compo ...... cations as medical chaperones.
@en
Characterizing antiprion compo ...... cations as medical chaperones.
@nl
type
label
Characterizing antiprion compo ...... cations as medical chaperones.
@ast
Characterizing antiprion compo ...... cations as medical chaperones.
@en
Characterizing antiprion compo ...... cations as medical chaperones.
@nl
prefLabel
Characterizing antiprion compo ...... cations as medical chaperones.
@ast
Characterizing antiprion compo ...... cations as medical chaperones.
@en
Characterizing antiprion compo ...... cations as medical chaperones.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Characterizing antiprion compo ...... cations as medical chaperones.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932